Evaluates the impact of fluoroquinolones on perturbations in blood glucose concentrations, namely hypoglycemia and hyperglycemia. Risk factors for dysglycemias; Details of the clinical trial safety data for the fluoroquinolones; Potential biologic mechanisms for fluoroquinolone-associated dysglycemias.